Checkmate 8HW: first-line dual immunotherapy decreases the risk of disease progression, reduces symptoms and improves quality of life of patients with metastatic colorectal cancer subtype

by VHIO

The Checkmate 8HW phase III clinical trial is evaluating the combination of nivolumab plus ipilimumab, two immunotherapy drugs, against chemotherapy as first-line treatment in patients with a subtype ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream